EurekAlert! News by Subject: Medicine & Health - News by Subject: Medicine & Health

Medicine & Health

Updates every hour. Last Updated: 26-Dec-2025 20:11 ET (27-Dec-2025 01:11 GMT/UTC)

Digital tools can improve dementia care – for people with dementia aging in place and their caregivers

George Mason University
Peer-Reviewed Publication

A new study reveals that digital health resources, while still inaccessible for many people, offer many benefits, including improved mental health and social connection.

Journal: Current Geriatrics Reports

Soil bacteria and fungi emerge as a top predictor of childhood allergic disease

American Geophysical Union
Reports and Proceedings

The unique blend of fungi and bacteria in a region’s soil may be the strongest factor explaining its rates of childhood allergic disease, with certain assemblages of soil critters appearing linked with better health outcomes, according to new research to be presented at AGU’s 2025 Annual Meeting in New Orleans.

Researchers discover that a hormone can access the brain by hitchhiking

Touro University
Peer-Reviewed Publication

While examining how exercise affects hormone transport, researchers at Touro University Nevada discovered that extracellular vesicles (EVs) - a communications system within our bloodstream - can carry the hormone precursor proopiomelanocortin (POMC) across human blood vessel barriers, including blood-brain barrier models, significantly more efficiently than POMC on its own.

Because the blood-brain barrier blocks so many existing therapies, this mechanism could have meaningful implications for future approaches to drug delivery, pain management, metabolic disorders, and stress response.

Journal: Proceedings of the National Academy of Sciences

Blood test may help identify which colon cancer patients benefit from NSAIDs

Alliance for Clinical Trials in Oncology
Peer-Reviewed Publication

A blood test could help doctors decide which patients with colon cancer should receive anti-inflammatory medication along with chemotherapy after surgery, according to new study in JAMA Oncology. Based on data from an Alliance for Clinical Trials in Oncology study, this finding could lead to more personalized treatments and better outcomes for patients.

Journal: JAMA Oncology
Funder: NIH/National Cancer Institute, Karen Guo Colon Cancer Fund, Project P, Douglas Gray Woodruff Chair in Colorectal Research Fund, Stone Research Fund, Pfizer, Natera

Researchers see dramatic drop in HIV-infected immune cells in patient after cancer treatment received

Johns Hopkins Medicine
Peer-Reviewed Publication

Advancements in HIV/AIDS research, drug development and clinical practice since the 1980s have made it possible for people living with HIV to lead long, productive lives and keep the virus in check at undetectable levels and nontransmissible as long as therapy is maintained. However, a cure ― completely ridding the body of the virus — has only been documented in a handful of patients who underwent complex and high-risk bone marrow transplants for life-threatening blood cancers such as leukemia or lymphoma.

Journal: Journal of Clinical Investigation
Funder: NIH/National Institutes of Health, NIH/National Institute of Dental and Craniofacial Research, NIH/National Institute of Allergy and Infectious Diseases, NIH/National Institutes of Health, NIH/National Institutes of Health

Support for parents with infants at pediatric check-ups leads to better reading and math skills in elementary school

NYU Langone Health / NYU Grossman School of Medicine
Peer-Reviewed Publication

Guiding parents to have pretend play and read aloud with their babies increased parental support of their children’s cognitive development and academic skills by the time they turned six—especially for families facing poverty.

Journal: PEDIATRICS
Funder: NIH/Eunice Kennedy Shriver National Institute of Child Health and Human Development

UTHealth Houston, in collaboration with UTMB Health, awarded $50 million by the state of Texas to lead ibogaine clinical trials

University of Texas Health Science Center at Houston
Grant and Award Announcement

UTHealth Houston, in collaboration with The University of Texas Medical Branch at Galveston (UTMB Health), has been awarded $50 million from the Texas Health and Human Services Commission to lead a collaborative two-year, multicenter research trial that will evaluate the effect of ibogaine on patients suffering from addiction, traumatic brain injury, and other behavioral health conditions.

41
42
43
44
45